Azemiglitazone

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameAzemiglitazone
Drug Alias NameAzemiglitazone potassiumMSDC-0602KMSDC-0602 (free acid)MSDC-0602 potassiumCIR-0602K
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersMitochondrial pyruvate carrier 2 inhibitors
TargetsMitochondrial pyruvate carrier 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetabolic Solutions, Inc
China Registration ClassN/A

Develop Information

Active CompaniesCirius Therapeutics IncUniversity Of Virginia
Inactive CompaniesMetabolic Solutions Development Company Llc
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A